Skip to content
Triall logo — Building towards a future of smarter, safer, and more-effici...

Triall

Building towards a future of smarter, safer, and more-efficient clinical trials.

Founded 2018 The Netherlands The Netherlands 6 employees Seed Total: $2.40M Health Care, Information Technology +4

General Information

Company Name Triall
Founded Year 2018
Location The Netherlands The Netherlands
Employees 6
Industries Health Care, Information Technology, Life Sciences +3
Funding Stage Seed
Offices as of Sep 2026
Maarssen, The Netherlands Amsterdam, The Netherlands
Social

BounceWatch is an independent company data service, not affiliated with Triall. To contact Triall, visit triall.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Triall compare?

A PDF of Triall and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Triall soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Triall

Triall, founded in 2018 and headquartered in The Netherlands, stands at the intersection of Health Care, Information Technology, and Life Sciences. Known for its slogan—"Building towards a future of smarter, safer, and more-efficient clinical trials."—the company is innovating the clinical trial landscape with its suite of SaaS and Web3 technologies.

Triall's offerings span the entire trial lifecycle, providing specialists with tools ranging from study design to post-study activities. A noteworthy upcoming feature, the Clinical Insights Exchange (CIX), promises data-driven insights for optimizing trial planning, leveraging privacy-enhancing technologies.

The firm also offers eClinical solutions tailored for various trial modalities—centralized, hybrid, and decentralized. Via strategic partnerships, Triall has cultivated a robust array of CRO services, ensuring comprehensive support in trial execution.

With a recent $2.40M Seed Round investment in July 2021, Triall appears well-poised to revolutionize clinical research through its innovative and extensive service capabilities.

Business keywords: clinical trials, clinical research, blockchain integration, eClinical solutions, decentralized trials, hybrid trials, centralized trials, CRO services, data privacy, wearable integration, interoperability, web-based solutions, mobile integration, Clinical Insight Exchange, end-to-end service

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $2.40M -
01 Jul 2021
Seed Round Undisclosed 1
Zokyo
16 Jun 2021
Seed Round Undisclosed -
01 Jan 2021

Triall Alternatives & Competitors

View All Alternatives
Triall vs
Datacapt
Datacapt France

Your Clinical Research. Better. Smarter, faster clinical data management for modern trials.

Pre-Seed
23 employees
Data Analytics, Digital Health
Triall vs

Contract Research Organization (CRO), We “Constantly Enhance and Accelerate” the Clinical Trial Bus...

20 employees
Biotechnology, Health Care
Triall vs
Mosio for Research
Mosio for Research United States

Mosio helps researchers engage, retain, and collect data from study subjects more efficiently and ef...

9 employees
Digital Health, Health Care

FAQ About Triall

Building towards a future of smarter, safer, and more-efficient clinical trials.
Triall was founded in 2018.
Triall is headquartered in The Netherlands. As of Sep 2026, it also has offices in Maarssen, The Netherlands and Amsterdam, The Netherlands.
Triall operates in Health Care, Information Technology, Life Sciences, Pharmaceutical, SaaS and Web3. Its work centres on clinical trials, clinical research, blockchain integration and eClinical solutions.
Triall has approximately 6 employees.
Triall has completed 3 funding rounds, raising a total of $2.40M. The latest funding stage is Seed.
Top alternatives and competitors to Triall include Datacapt, Syncorp Health Pvt Ltd, Mosio for Research, Ophidia Medical Technologies, Complion. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Triall and Datacapt are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Triall, https://bouncewatch.com/company/triall, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout